Wird geladen...
miR‐181a/b therapy in lung cancer: reality or myth?
Despite substantial progress in oncology, lung cancer remains the number one malignancy in terms of both incidence and mortality rates, and there thus remains an urgent need for new therapeutic alternatives. MicroRNA (miRNA) have an important role in cancer initiation and progression due to their ca...
Gespeichert in:
| Veröffentlicht in: | Mol Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6322195/ https://ncbi.nlm.nih.gov/pubmed/30548184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12420 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|